Join the conversation #ENASymp
ENA 2020 is the drug development and translational research meeting, focusing on preclinical and phase I studies, enabling and facilitating in-depth scientific discussions on the latest developments in targets and drugs.
Attracting academics, scientists and pharmaceutical industry representatives from across the globe to discuss the latest innovations in drug development, target selection and the impact of new discoveries in molecular biology.
ENA is at the forefront of cancer drug development meetings
Presentation of ground-breaking new data
Networking opportunities with world leading experts
Influencing future clinical cancer research to improve survival and
quality of life of cancer patients.
News from ENA 2020
Programme
Sir Peter Ratcliffe, 2019 Nobel Prize Winner
to present Michel Clavel Lecture…
With ground-breaking new data presentations and unrivalled networking opportunities with world leading experts, ENA 2020 allows you to join in and influence the discussion on the future of translational and clinical cancer research.
Michael Clavel Lecture: Sir Peter Ratcliffe (UK)
Keynote Lecture: Toni Choueiri (USA)
Sponsorship and Exhibition
The ENA Symposium offers exciting opportunities to achieve the highest level of exposure to academics, scientists and pharmaceutical industry representatives from across the globe.
Partners
